Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis-Reference-Cited by-同舟云学术

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis

Published:2012-10 Issue:4 Volume:207 Page:266.e1-266.e12
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Gallos Ioannis D.,Yap Jason,Rajkhowa Madhurima,Luesley David M.,Coomarasamy Arri,Gupta Janesh K.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference48 articles.

1. Cancer Statistics registrations: registrations of cancer diagnosed in 2007, England,2010

2. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women;Escobedo;Obstet Gynecol,1991

3. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis;Gallos;Am J Obstet Gynecol,2010

4. Current management of endometrial hyperplasia—a survey of United Kingdom consultant gynaecologists;Gallos;Eur J Obstet Gynecol Reprod Biol,2011

5. Classification of endometrial hyperplasia,2002

Cited by 278 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan;Journal of Gynecologic Oncology;2025

2. Translating biological insights into improved management of endometrial cancer;Nature Reviews Clinical Oncology;2024-08-28

3. Progression of fertility-sparing treatment for atypical endometrial hyperplasia in a woman with lynch syndrome: a case report and review of the literature;Frontiers in Oncology;2024-08-12

4. Analysis of assisted reproductive outcomes for gynecologic cancer survivors: a retrospective study;Reproductive Biology and Endocrinology;2024-08-06

5. Update on the oncologic and obstetric outcomes of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial cancer;Journal of Obstetrics and Gynaecology Research;2024-08-02